Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Covid-19 and the Functionality of Antivirals: The Day After Tomorrow Publisher Pubmed



Sharifan A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmaceutical Care, Sina Hospital, Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran

Source: Health Security Published:2022


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Thrombotic Storm in Coronavirus Disease 2019: From Underlying Mechanisms to Its Management, Journal of Medical Microbiology (2022)
2. Remdesivir: Treatment of Covid-19 in Special Populations, Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
3. Higher Covid-19 Pneumonia Risk Associated With Anti-Ifn-Α Than With Anti-Ifn-Ω Auto-Abs in Children, Journal of Experimental Medicine (2024)
4. Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns, Science Immunology (2023)
5. Drug Prescription Patterns and Their Association With Mortality and Hospitalization Duration in Covid-19 Patients: Insights From Big Data, Frontiers in Public Health (2023)
6. Oral Antiviral Treatments for Covid-19: Opportunities and Challenges, Pharmacological Reports (2022)
7. Effects of Remdesivir on In-Hospital and Late Outcomes of Patients With Confirmed or Clinically Suspected Covid-19: A Propensity Score-Matched Study, Acta Medica Iranica (2022)
8. Evaluation of Clinical Outcomes in Covid-19 Patients Receiving Remdesivir in Outpatient Setting, Iranian Journal of Pharmaceutical Sciences (2024)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (2)
Seyed Ahmad Seyed Alinaghi (2)
Other Related Docs
9. Clinical, Demographic, and Laboratory Characteristics of Covid -19 Infection and Risk of In-Hospital Mortality. a Single Center 4, Caspian Journal of Internal Medicine (2022)
10. Changes in the Global Mortality Rate Over Time in Association With the Covid-19 Pandemic Until 2032, Coronaviruses (2025)
11. Cardiovascular Implications of the Covid-19: Management of Complications and Drug Safety Concerns, Journal of Research in Medical Sciences (2022)
12. Therapeutic Strategies for Covid-19 Patients: An Update, Infectious Disorders - Drug Targets (2022)
13. Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments, Cardiology in Review (2022)
14. Remdesivir-Associated Significant Bradycardia: A Report of Three Cases, Journal of Tehran University Heart Center (2021)
15. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
16. Coronavirus Disease 2019 (Covid-19) in Pediatric Patients With Autoimmune Disorders, European Journal of Pediatrics (2023)
17. Investigation of Effective Drugs in the Treatment of Patients With Covid-19, Journal of Iranian Medical Council (2023)
18. Repurposed Antiviral Drugs for Covid-19 — Interim Who Solidarity Trial Results, New England Journal of Medicine (2021)
19. Comparison of the Eight Different Treatment Regimens for the Hospitalized Patients With Covid-19: A Retrospective Cohort Study, Journal of Cellular and Molecular Anesthesia (2021)
20. Covid-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment, Seminars in Thrombosis and Hemostasis (2023)
21. Effectiveness of Fortified Garlic Extract Oral Capsules As Adjuvant Therapy in Hospitalized Patients With Coronavirus Disease 2019: A Triple-Blind Randomized Controlled Clinical Trial, Current Therapeutic Research - Clinical and Experimental (2023)
22. Case Report: Covid-19-Associated Rhinosinusitis Mucormycosis Caused by Rhizopus Arrhizus: A Rare But Potentially Fatal Infection Occurring After Treatment With Corticosteroids, American Journal of Tropical Medicine and Hygiene (2021)